Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aerovance
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aerovance

Aerovance

Inactive

Aerovance Inc., a biopharmaceutical firm in California, develops medicines for respiratory and allergic diseases.

HQ
Berkeley, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Aerovance Inc., founded in California, is a biopharmaceutical company dedicated to developing and marketing innovative medicines for respiratory and allergic diseases. The company's core mission is to address the root causes of these conditions, thereby improving patient outcomes and quality of life. Aerovance's primary product is a medicine molecule specifically designed to target asthma at its source, offering a novel approach to treatment in a market that urgently needs new solutions.

Notable figures affiliated with Aerovance include experienced professionals from the biopharmaceutical industry, contributing their expertise to advance the company's mission. The company has attracted significant investment from key players in the healthcare sector, underscoring its potential impact. Aerovance's achievements include the development of cutting-edge treatments that have shown promise in clinical trials, positioning it as a leader in respiratory and allergic disease therapeutics.

Aerovance - Similar Companies

Aer Therapeutics logo

Aer Therapeutics

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Aerwave Medical logo

Aerwave Medical

aerwavemed.com

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Aeovian Pharmaceuticals logo

Aeovian Pharmaceuticals

aeovian.com

Aero Therapeutics logo

Aero Therapeutics

AerovectRx logo

AerovectRx

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

Respira Therapeutics logo

Respira Therapeutics

Pulmatrix logo

Pulmatrix

pulmatrix.com

Theron Pharmaceuticals logo

Theron Pharmaceuticals

Respirics logo

Respirics

Pulmokine logo

Pulmokine

pulmokine.net

Respirogen logo

Respirogen

respirogen.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Aerovance - Quick Facts

Who are Aerovance's competitors?

Companies similar to Aerovance include Aer Therapeutics, Theravance Biopharma, Aerwave Medical and Avalyn Pharma.

When was Aerovance founded?

Aerovance was founded in 2004.

Where is Aerovance's headquarters located?

Aerovance's headquarters is located in Berkeley, CA, US.

When was Aerovance's last funding round?

Aerovance's most recent funding round was for $500k (USD) in March 2011.

How much has Aerovance raised to-date?

As of Mar 21, 2011, Aerovance has raised a total of $152.5M (USD).

Aerovance - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medicines
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified